Evaluation of Sympathetic Activity by 123I-Metaiodobenzylguanidine Myocardial Scintigraphy in Dilated Cardiomyopathy Patients With Sleep Breathing Disorder-Reference-Cited by-同舟云学术

Evaluation of Sympathetic Activity by 123I-Metaiodobenzylguanidine Myocardial Scintigraphy in Dilated Cardiomyopathy Patients With Sleep Breathing Disorder

Published:2009 Issue:4 Volume:73 Page:686-690
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Nanjo Shuji¹,Yamashiro Yoshihiro²,Fujimoto Shinichiro¹,Yamashina Shohei¹,Nakanishi Rine¹,Fukunaga Shunji¹,Inoue Aritomo¹,Namiki Atsushi¹,Nakano Hajime¹,Yamazaki Junichi¹

Affiliation:

1. Division of Cardiovascular Medicine, Department of Internal Medicine, Ohmori Hospital, Toho University School of Medicine

2. Sleep Disorders Center, Ota General Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/73/4/73_CJ-08-0562/_pdf

Reference29 articles.

1. 1. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-1435.

2. 2. Cohn JN, Tognoni G, Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001; 345: 1667-1675.